<DOC>
	<DOCNO>NCT02790541</DOCNO>
	<brief_summary>Recent study show preliminary evidence HBOT therapeutic effect angiogenesis , increase tissue blood flow oxygenation correlate tissue function . Our primary hypothesis HBOT beneficial effect mention organ associate aging-related malfunction due restore mitochondrial function , mobilization stem cell induction angiogenesis .</brief_summary>
	<brief_title>Angiogenesis Induced Elderly Hyperbaric Oxygen Therapy</brief_title>
	<detailed_description>The paradigm The accumulation damage molecule , cell tissue lifetime contributes age eventually lead frailty malfunction . The past decade see fundamental advance understand age process raise optimism intervention slow age may horizon . The age process link energy deficit due tissue hypoxia mitochondrion dysfunction . - Mitochondria dysfunction- Mitochondria primary generator energy mean ATP synthesis dysfunction lead cellular function decline degenerative change . In addition , mitochondrion dysfunction stem cell decrease capability tissue regeneration . - Tissue hypoxia- Atherosclerosis chronic inflammatory response damage arterial blood vessel . It begin childhood progress throughout life . A vicious cycle occur mitochondrial dysfunction accelerate atherosclerosis wan microvasculature , result decrease blood supply ensue relative tissue hypoxia . The decrease oxygen supply mitochondrion exacerbate mitochondrial dysfunction . Hyperbaric oxygen increase partial pressure dissolve ( non-hemoglobin-bound ) oxygen 20-30 fold produce two main effect . First , eliminate relative tissue hypoxia induce atherosclerosis . Second , mitochondrion function directly influence partial pressure dissolve oxygen , hyperbaric oxygen amend mitochondrial dysfunction . Thus , investigator suggest hyperbaric oxygen novel method break vicious cycle degeneration perhaps even reverse age process . The study design prospective crossover study aim evaluate therapeutic effect HBOT Brain , Cardiovascular Immune system , Skin , Erectile ( sexual function ) , liver Kidneys , age population . After sign informed consent form , patient invite baseline evaluation . All patient would evaluate 3 time - baseline , 3 month follow , additional 3 month HBOT protocol . The evaluation include cognitive assessment , questionnaire , MRI scan , blood test skin photograph biopsy . In addition , blood test draw 20th , 40th 60th session stem cell mitochondria test . Patients receive 60 daily session , 5 days/week , 90 minute 5 minute air break every 30 minute , 100 % oxygen 2 ATA .</detailed_description>
	<criteria>Ageâ‰¥ 65 year Capability sign inform consent . No cardiac cerebrovascular ischemia previous event one year prior inclusion . Previous treatment HBOT reason last 3 month prior inclusion . Any history malignancy last year prior inclusion . Severe cognitive decline ( MMSA &lt; 17 ) Severe chronic renal failure ( GFR &lt; 30 ) Uncontrolled diabetes mellitus ( HbA1C &gt; 8 , fast glucose &gt; 200 ) Immunosuppressant reason Contraindications perform MRI : claustrophobia , allergy gadolinium , foreign body , pacemaker , etc . Active Smoking . Pulmonary disease severe emphysema , moderatesevere obstructive disease . Medical condition deem investigator make patient ineligible protocol investigation .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>age</keyword>
	<keyword>HBOT</keyword>
	<keyword>reverse</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>elderly</keyword>
	<keyword>mitochohndria</keyword>
</DOC>